Table 6.
No | Entity A | Entity C | Ranking score | Co-occurrence | Word2Vec | COALS | Random indexing |
---|---|---|---|---|---|---|---|
1 | Alzheimer’s disease | Patients | 1 | 1 | 0.5444 | 0.0413 | 0.0206 |
2 | Alzheimer’s disease | Disease | 0.9065 | 0.1167 | 0.98 | 0.8615 | 0.8585 |
3 | Alzheimer’s disease | Brain | 0.5989 | 0.023 | 0.6085 | 0.1052 | 0.0859 |
4 | Alzheimer’s disease | Dementia | 0.5902 | 0.1187 | 0.733 | 0.6591 | 0.6518 |
5 | Alzheimer’s disease | Impaired cognition | 0.5013 | 0.0637 | 0.6737 | 0.0413 | 0.0206 |
6 | Alzheimer’s disease | Therapeutic procedure | 0.4828 | 0.0512 | 0.6606 | 0.0413 | 0.0206 |
7 | Alzheimer’s disease | Neurodegenerative disorders | 0.4371 | 0.0444 | 0.7707 | 0.0413 | 0.0206 |
8 | Alzheimer’s disease | Persons | 0.408 | 0.0879 | 0.6314 | 0.0413 | 0.0206 |
9 | Alzheimer’s disease | Amyloid | 0.4018 | 0.0357 | 0.6118 | 0.1159 | 0.0968 |
10 | Alzheimer’s disease | Pharmaceutical preparations | 0.394 | 0.03 | 0.7011 | 0.0413 | 0.0206 |
11 | Alzheimer’s disease | APP gene | 0.3845 | 0.0098 | 0.5346 | 0.0413 | 0.0206 |
12 | Alzheimer’s disease | Amyloid beta-protein precursor | 0.3751 | 0.0211 | 0.3492 | 0.0413 | 0.0206 |
13 | Alzheimer’s disease | Functional disorder | 0.3746 | 0.0354 | 0.7702 | 0.0413 | 0.0206 |
14 | Alzheimer’s disease | Apolipoprotein E | 0.3707 | 0.0292 | 0.5656 | 0.052 | 0.0315 |
15 | Alzheimer’s disease | Parkinson’s disease | 0.3702 | 0.0052 | 0.9802 | 0.0413 | 0.0206 |
16 | Alzheimer’s disease | Population group | 0.3692 | 0.0464 | 0.629 | 0.0413 | 0.0206 |
17 | Alzheimer’s disease | Pathogenesis | 0.3685 | 0.0405 | 0.7519 | 0.0413 | 0.0206 |
18 | Alzheimer’s disease | Dementia, vascular | 0.3552 | 0.0095 | 0.7878 | 0.6494 | 0.5067 |
19 | Alzheimer’s disease | Nerve Degeneration | 0.3546 | 0.0282 | 0.712 | 0.0413 | 0.0206 |
20 | Alzheimer’s disease | Entire hippocampus | 0.3541 | 0.0038 | 0.5782 | 0.0413 | 0.0206 |